Baystate Wealth Management »

Enliven Therapeutics shares owned by Baystate Wealth Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Baystate Wealth Management from 13F filings

Historical chart of Baystate Wealth Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Baystate Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Baystate Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $692 50 13.84
2023-09-30 $683 50 13.66
2023-06-30 $1.0k 50 20.42
2023-03-31 $1.1k 50 21.90

More positions owned by Baystate Wealth Management

Ishares Russell Top 200 Growth Etf Etf (IWY)
Spdr S&p World Ex-us Etf (SPDW)
Invesco Ftse Rafi Us 1000 Etf Etf (PRF)
Ishares S&p 500 Index Etf (IVV)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Value Etf Etf (VTV)
Invesco Russell 1000 Dynamic Multifactor Etf Etf (OMFL)
Blackrock Ultra Short-term Bond Etf Etf (ICSH)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Tr Russell Midcap Index Etf (IWR)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Vanguard S&p Small-cap 600 Etf Etf (VIOO)
Spdr Barclays Capital Short Term Corp Bd Etf (SPSB)
Vanguard Total Bond Market Etf Etf (BND)
Ishares Msci Usa Value Factor Etf Etf (VLUE)

View all positions for Baystate Wealth Management

Top funds holding Enliven Therapeutics

OrbiMed Advisors
5AM Venture Management
VR Adviser
Commodore Capital
Citadel Advisors
Fairmount Funds Management
RA Capital Management
Vanguard Group
Boxer Capital
Henderson Group
Logos Global Management
Charles Schwab Investment Management
Bank of New York Mellon
BML Capital Management
Barclays

View all funds holding Enliven Therapeutics